The Medicines Company announced the launch of a new formulation of Minocin (minocycline) for Injection. The new formulation contains magnesium sulfate, an excipient, which allows for administration at ...
TOKYO, Oct 4, 2022 - (JCN Newswire) - - Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Future & Beyond", it has ...
EXTON, PA — ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an oral NAD+ formulation designed to deliver ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a ...
For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...
Credit: Baxter. Zosyn premix is supplied in 2.25g in 50mL, 3.375g in 50mL, and 4.5g in 100mL presentations. Baxter has announced the launch of a frozen premix formulation of Zosyn (piperacillin and ...
CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), announced ...
The National Pharmaceutical Pricing Authority (NPPA) has once again extended its mandate to Pune-based Serum Institute of India (SII) to continue manufacturing two of its scheduled formulations ...
WuXi STA, a subsidiary of WuXi AppTec, reports that a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened ...
Fiber Dynamics, Inc. in Wichita, Kansas, is a specialist in the field of highly sophisticated composites solutions. With the investment in a GX 1100-4300 DCIM from KraussMaffei, the company is moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results